Loading...
The Greater Cannabis Company, Inc.
GCAN•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.00
$-0.00(-25.00%)
The Greater Cannabis Company, Inc. (GCAN) Stock Overview
Explore The Greater Cannabis Company, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for GCANStats details for GCAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for GCANAnalyst Recommendations details for GCAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
CEO
Mr. Aitan Zacharin
Employees
1
Headquarters
15 Walker Avenue, Baltimore, MD
Founded
2018